$103 Million is the total value of Blue Water Life Science Advisors, LP's 8 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CDNA | New | CAREDX INC | $7,920,300 | – | 510,000 | +100.0% | 7.70% | – |
| TXG | Buy | 10X GENOMICS INC | $4,473,500 | -38.7% | 230,000 | +18.3% | 4.35% | -36.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NATERA INC | 15 | Q2 2024 | 53.0% |
| GUARDANT HEALTH INC | 15 | Q2 2024 | 21.3% |
| AKOYA BIOSCIENCES INC | 11 | Q2 2024 | 23.4% |
| ADAPTIVE BIOTECHNOLOGIES COR | 10 | Q1 2024 | 17.7% |
| CAREDX INC | 8 | Q2 2024 | 19.0% |
| MAXCYTE INC | 8 | Q2 2024 | 11.8% |
| THERMO FISHER SCIENTIFIC INC | 6 | Q4 2023 | 16.0% |
| BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
| SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
| CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| SC 13G | 2024-08-28 |
| 13F-HR | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.